Rifampin's Effect on Tigecycline Dosing
Rifampin induces CYP3A4 enzymes, accelerating tigecycline metabolism and reducing its plasma exposure by about 50-60%. Tigecycline's standard IV loading dose (100 mg) followed by 50 mg every 12 hours remains unchanged, but rifampin co-administration requires increasing the maintenance dose to 100 mg every 12 hours to compensate.[1][2]
Why This Interaction Happens
Tigecycline undergoes minimal CYP metabolism but is affected by P-glycoprotein and BCRP efflux transporters, which rifampin—a potent inducer—upregulates alongside CYP3A4. Steady-state AUC drops significantly (e.g., 55% in studies), shortening half-life from 27-42 hours to under 20 hours.[1][3]
Clinical Evidence from Studies
In healthy volunteer trials, rifampin 600 mg daily with tigecycline lowered C_max by 32% and AUC by 55%. Dose doubling restored tigecycline levels comparable to monotherapy. Similar reductions occur with other CYP3A4 inducers like phenytoin.[2][4]
When to Adjust in Practice
Adjust only during concurrent rifampin use for infections like tuberculosis or staphylococcal disease. Monitor for efficacy in serious cases (e.g., complicated intra-abdominal infections). No adjustment needed when stopping rifampin—return to standard 50 mg q12h.[1][5]
Potential Risks of Skipping Adjustment
Underdosing risks treatment failure, especially against multidrug-resistant bacteria where tigecycline is reserved. Overdosing (without rifampin) increases nausea, vomiting, or pancreatitis risk without added benefit.[3][6]
Alternatives if Interaction Concerns You
Switch to non-interacting options like meropenem or vancomycin, or use rifabutin (weaker inducer). Time doses apart minimally helps but doesn't eliminate the effect.[5]
[1]: Tigecycline Prescribing Information (Pfizer)
[2]: Drug Interactions with Tigecycline (Clinical Pharmacology Study)
[3]: Antimicrobial Agents and Chemotherapy: Rifampin-Tigecycline Interaction
[4]: FDA Drug Approval Package for Tygacil
[5]: Lexicomp: Tigecycline Drug Interactions
[6]: UpToDate: Tigecycline Overview